|
Volume 271, Number 22,
Issue of May 31, 1996
pp. 13140-13146
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Identification of a Region of Bacillus subtilis Ffh,
a Homologue of Mammalian SRP54 Protein, That Is Essential for Binding
to Small Cytoplasmic RNA*
(Received for publication, November 27, 1995, and in revised form, March 7, 1996)
Kei
Kurita
,
Kiyofumi
Honda
,
Satoru
Suzuma
,
Hiromu
Takamatsu
,
Kouji
Nakamura
and
Kunio
Yamane
From the Institute of Biological Sciences, University of Tsukuba,
Tsukuba-shi, Ibaraki 305, Japan
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES
ABSTRACT
Bacillus subtilis Ffh and scRNA are
homologues of mammalian SRP54 and SRP RNA, respectively, which are
components of the eukaryotic signal recognition particle (SRP). Ffh
(446 amino acids) interacts with scRNA to form a stable complex
in vivo. Here, we identified an RNA-binding domain of Ffh.
The results obtained using a series of deletion mutants show that amino
acid positions 364 to 432 in the C-terminal region of Ffh correlates
with its ability to bind RNA. The amino acid sequence of this region is
well conserved among members of the SRP54 protein family. This sequence
contains two hydrophobic regions (h2, 364 to 391, and h3, 416 to 435),
separated by the positively charged amino acid motif,
398RRKRIAKGSG407. Among the basic amino acid
residues in this region, Arg-401 was essential for binding to scRNA,
but Arg-399 and Lys-400 were not. The co-existence of Arg-398 and
Lys-404 was necessary for the same affinity as wild type Ffh. The two
glycine residues of the 405GSG407 were also
essential. MH23 peptide (91 amino acids) encompassing from 356 to 446,
consisting of h2-RRKRIAKGSG-h3, bound scRNA with the same affinity as
wild type Ffh, whereas a 24-amino acid synthetic peptide
392DIINASRRKRIAKGSGTSVQEVNR415 did not. The
region containing two hydrophobic segments separated by the positively
charged motif is the minimal requirement of Ffh for RNA binding.
INTRODUCTION
In mammals, the signal recognition particle
(SRP)1 plays an important role in targeting
secretory proteins to the membrane of the endoplasmic reticulum.
Mammalian SRP is a ribonucleoprotein particle composed of one RNA
molecule (7 S RNA here referred to SRP RNA) and six polypeptides of 9,
14, 19, 54, 68, and 72 kDa (1, 2). SRP interacts with a signal sequence
of a nascent polypeptide as it emerges from the ribosome, then the
elongation of the nascent chain is inhibited (3, 4). The complex
consisting of SRP, nascent polypeptide chain, and ribosome is targeted
and binds to the heterodimeric SRP receptor in the endoplasmic
reticulum membrane (3, 4, 5).
The SRP54 subunit of SRP has a central function in recognizing and
binding signal sequences (6, 7, 8). This protein comprises the
structurally distinct, N-terminal G- and C-terminal M-domains (9, 10).
The G-domain contains three GTP-binding motifs, and it may play an
essential role in mediating the interaction between SRP and the SRP
receptor (11). The M-domain is characterized by a high content of
predominantly positively charged residues and an abundance of
methionine residues. Moreover, there are three putative amphipathic
helices in the M-domain (9). The M-domain is a binding site for the
signal sequence and SRP RNA (12, 13, 14, 15). The three-dimensional structure
of SRP54 protein has been determined by scanning transmission electron
microscopy (STEM) (16). The scanning transmission electron microscopy
image consisting of one larger and one smaller domain (probably
representing the G- and M-domain, respectively) joined by slender
linker, was in agreement with genetic and biochemical data.
A protein homologous to SRP54 has been identified in Eukaryotes and
Eubacteria (3, 17, 18, 19, 20, 21, 22, 23, 24). The features of the two structural domains (G-
and M-domains) of SRP54 are highly conserved in these proteins.
Furthermore, these proteins form an SRP-like complex with RNA molecules
that are structurally related to mammalian SRP RNA (25, 26, 27, 28). The
binding of Ffh to 4.5 S RNA, which are homologues of SRP54 and SRP RNA
in Escherichia coli, respectively, is essential for the
signal recognition function (29). Larsen and Zweib (30) proposed that
SRP RNA consists of 8 helices (numbered 1 to 8). The nucleotide
sequence in the region corresponding to the helix 8 is highly conserved
among SRP RNA homologues, and this loop region mediates the binding to
SRP54 and its homologues (17, 31, 32). The SRP RNA homologue of
Bacillus subtilis scRNA (small cytoplasmic RNA) lacks
helices 6 and 7, whereas those of E. coli 4.5 S RNA lack
helices 1, 2, 3, 4, 6, and 7 as well as part of 5 (30). Furthermore,
mammalian SRP54 can bind to E. coli 4.5 S RNA in
vitro (33). These findings indicated that the RNA-binding form of
SRP and related complexes contain common features. The RNA-binding
domain of the homologue of SRP54 in Mycoplasma mycoides is
located in the M-domain (34), and it has been proposed that the
hydrophilic faces of the predicted amphipathic -helices in the
M-domain contact SRP RNA (11, 14, 15). However, the RNA-binding region
of Ffh has not yet been analyzed in detail.
B. subtilis can produce large amounts of extracellular
enzymes. We demonstrated that it contains SRP-like particles and that
they are closely involved in enzyme secretion (26). B.
subtilis Ffh protein has features very similar to these of SRP54
(23). The Ffh also has G-domain and M-domain. A phylogenetic comparison
of SRP54 protein has revealed three highly hydrophobic regions
( ydrophobic regions 1, 2, and 3 are referred to as h1, h2,
and h3) in the M-domain (23). The h1, h2, and h3 regions correspond to
amino acid positions 307 to 331, 364 to 391, and 416 to 435,
respectively, in B. subtilis Ffh. To determine the essential
region of Ffh protein for the binding to scRNA of a homologue of SRP
RNA, we constructed several mutant Ffh proteins of B.
subtilis into which deletions and amino acid replacements were
introduced. We then determined their RNA-binding activity using the
filter assay (34). On the basis of the RNA-binding activity of
wild-type and mutants of Ffh, we defined a minimal RNA-binding domain
encompassing h2 to h3 in the M-domain. Moreover, in the
398RRKRIAKGSG407 sequence located between h2
and h3, we found that Arg-401, Gly-405, and Gly-407 are essential for
RNA binding.
EXPERIMENTAL PROCEDURES
Plasmid Construction for Large Deletion Mutants of Ffh
An
E. coli plasmid expressing B. subtilis wild-type
Ffh with a hexahistidine tag at its C terminus (Ffh-WT) was constructed
as follows. A 1.3-kb NcoI-BglII fragment of
pTUE815 (26) was inserted into NcoI-BglII sites
of pQE60BS, in which BamHI and SmaI linker DNA
fragments were introduced into HindIII and EcoRI
sites of pQE60, respectively. The resulting plasmid was designated
pTUE920.
The plasmid expressing Ffh- G was constructed by digesting pTUE920
with HindIII to remove the 472-bp HindIII
fragment encoding part of the G-domain, followed by re-ligation. The
plasmid expressing Ffh- C was constructed by digesting pTUE920 with
NspI and BglII, to remove the 44-bp
NspI-BglII fragment encoding the 14 C-terminal
amino acids. Each cohesive end of the 4.7-kb
NspI-BglII fragment was digested with S1 nuclease
and re-ligated. The plasmid expressing Ffh- h2 was constructed from
pTUE920 by digestion with AvaI and NaeI to remove
the 178-bp AvaI-NaeI fragment encoding amino acid
positions 378 to 397 containing h2 region. Cohesive ends of the 4.6-kb
AvaI-NaeI fragment were filled by T4 DNA
polymerase and re-ligated.
The C-terminal part of Ffh was deleted further as follows. These DNA
fragments were produced by the polymerase chain reaction (PCR) using
four oligonucleotide primers and pTUE905 (23) as the template, which
included the wild-type ffh gene. The synthetic
oligonucleotide N (5 -CAAACCATGGCATTTCAA-3 ) containing a novel
NcoI site was used as one primer, and the synthetic
oligonucleotides T2 (5 -CAGATCTCGGCTGTTCTTTTTCAA-3 ), 23
(5 -CAGATCTCAGGCCCTTCATTTTAC-3 ), C1
(5 -CAGATCTTTCCTGTACGGATGTCCCG-3 ), and G1
(5 -CAGATCTGCCGAGAATCCTTGATGC-3 ), all of which contained a novel
BglII site, were used as the other primers with which to
construct plasmids expressing Ffh- M, Ffh- h3, Ffh- h3 , and
Ffh- h23, respectively. The resulting PCR fragments were digested
with NcoI and BglII and inserted into the
NcoI-BglII sites of pQE60BS. The plasmid
expressing Ffh- h1 was constructed using two DNA fragments. A DNA
fragment was amplified by PCR using the synthetic oligonucleotides N
and HO1 (5 -CAGGCCTGTGCTTTTTCAATC-3 ) containing a StuI
site, then digested with NcoI and StuI. Another
DNA fragment was also amplified by PCR using the synthetic
oligonucleotides O2 (5 -CAGGCCTTGAAAAACATCCAAGTTG-3 ), which contained
a novel StuI site, and C
(5 -GGATCCAGATCTCATAAAAGGTAGCTT-3 ), which contained a novel
BglII site, then digested with BglII and
StuI. These two DNA fragments were ligated and inserted into
the NcoI-BglII sites of pQE60BS. The plasmid
expressing the Ffh- h12 was constructed as follows. A DNA fragment of
the 5 end of ffh was amplified by PCR using synthetic
oligonucleotides N and HO1 and digested with NcoI and
StuI. To prepare a DNA fragment of the 3 end of
ffh, we introduced the novel StuI site on
pTUE920. A HindIII-BamHI restriction fragment of
plasmid pTUE920 was introduced into M13mp19, and a single stranded DNA
was prepared as a template for site-directed mutagenesis, which
proceeded using the ``Mutan K'' system (TAKARA SHUZO Co., Ltd.,
Tokyo) based on the method of Kunkel et al. (35, 36). The
nucleotide sequence of ACCGTC at position 1951 to 1956 in the
ffh gene was changed to AGCGCT using the oligonucleotide
STUI-A (5 -CTGCTTAAGCAAGCGCTTGACTTCCTG-3 ). We then changed the
nucleotide sequence of AGCGCT to AGGCCT, which was a novel
StuI site, using the oligonucleotide STUI-B
(5 -GCTTAAGCAAGGCCTTGACTTCC-3 ). The BstXI-BamHI
fragment, which was introduced into the novel StuI site, was
checked by sequencing and ligated into the
BstXI-BamHI site of pTUE920. The resulting
plasmid was designated pTUE921. A NcoI-StuI
fragment from pTUE921 was then ligated with the PCR-amplified fragments
of N and HO1.
Plasmid Construction for Ffh Mutants Using the Site-directed
Mutagenesis
The plasmids expressing the Ffh derivatives carrying
amino acid replacements and short deletions were constructed by
site-directed mutagenesis as described above. The synthetic
oligonucleotides used were: K364M (5 -TGGATGTTCATCAGGCCC-3 ), K371M
(5 -TTCAGCTGCATTTCATCA-3 ), H375Q (5 -GTCTCCACTTGATTCAG-3 ),
QQQQ (5 -GCAATCTGCTGCTGCTGGCTGG-3 ), F420Q
(5 -ATTTCATCTTGCTGCTTAA-3 ), K428M (5 -TCATCTGCATCATCATT-3 ),
K435M (5 -TTCTTGCCCATTGACATG-3 ), GSG
(5 -CTGTACGGATGTTTTTGCAATCCG-3 ), RQQR (5 -GCAATCCGCTGCTGCCGGCTG-3 ),
RQQQ (5 -CTTTTGCAATCTGCTGCTGCC-3 ), QQQR
(5 -CCGCTGCTGCTGGCTGGC-3 ), PSP
(5 -GGATGTCGGGCTTGGTTTTGCAATCCG-3 ), ASA
(5 -GGATGTCGCGCTTGCTTTTGCAATCCG-3 ), PSG (5 -CCCGCTTGGTTTTGCAATCCG-3 ),
and GSP (5 -GGATGTCGGGCTTCCTTTTGCAATCCG-3 ).
Using the oligonucleotides and the single-stranded DNA described above
as the template, the respective replacements and a short deletion were
introduced, then the BstXI-BamHI fragment was
ligated into the BstXI-BamHI sites of pQE60BS.
The plasmid expressing the three K404Q derivatives, RRKR-K404Q,
RQQR-K404Q, and QQQR-K404Q, was constructed using the same
oligonucleotide (5 -CCGCTTCCTTGTGCAATCCGC-3 ) and respective templates
of single-stranded DNA. The single-stranded DNA templates for
RRKR-K404Q, RQQR-K404Q, and QQQR-K404Q derivatives were prepared from
M13mp19 which contained HindIII and BamHI
fragments of the plasmid expressing Ffh-WT (pTUE920), RQQR, and QQQR,
respectively. These plasmids were introduced followed by the
BstXI-BamHI fragment ligated into
BstXI-BamHI sites of pQE60BS.
Plasmid Construction to Prepare MH23 Polypeptide
The
plasmid expressing the Ffh-MH23 was constructed as follows. A DNA
fragment was amplified by PCR using the synthetic oligonucleotides C
and N3 (5 -GCCATGGGTGCAGGTAAAATGAAGG-3 ), the latter of which contained
a novel NcoI site. This fragment was digested with
BglII and NcoI and inserted into the
BglII and NcoI sites of pQE60BS.
Synthesis of Peptide
A synthetic 24-mer peptide
corresponding to the region between B. subtilis Ffh amino
acid positions 392 to 415 (DIINASRRKRIAKGSGTSVQEVNR) were synthesized
on BIOSYN 2000 peptide synthesizer (Lewisville, TX) by solid phase Fmoc
(N-(9fluorenyl)methoxycarbonyl) chemistry (37). Upon
completion of synthesis, the resin is treated with 95% trifluoroacetic
acid, containing 1% thioanisole as a scavenger. The peptide are
purified using the BIOCAD perfusion chromatography system from
Perseptive Biosystems (Framingham, MA). The separation column used is
the R2M 20-µ porous beads, also from Perseptive Biosystems. A
gradient from 20% solvent A to 100% solvent B is used. Solvent A is
20% aqueous acetonitrile containing 0.1% trifluoroacetic acid.
Solvent B is 100% acetonitrile containing 0.1% trifluoroacetic acid.
The purity of the peptide was more than 95%.
Expression and Purification of Ffh and Its Derivatives with the
Hexahistidine Tag
Each recombinant protein was expressed in
E. coli M15 harboring pREP4 (Qiagen) grown for 5 h at
37 °C in L-broth (150 ml) supplemented with 2 mM IPTG.
Cells were harvested and suspended in 10 ml of sonication buffer (20
mM Tris-HCl (pH 8.0), 5 mM MgCl2,
150 mM NaCl, 10% glycerol, 0.05% Nonidet P-40, 0.1
mM phenylmethylsulfonyl fluoride). After freezing and
thawing the suspension, a half-volume of glass beads was added and the
mixture was vigorously vortex-mixed for 10 min at 4 °C. The
supernatant was separated from the glass beads that went to the bottom
and centrifuged at 10,000 × g for 15 min at 4 °C. The
precipitate was dissolved in 10 ml of buffer A (0.1 M
NaH2PO4, 0.01 M Tris-HCl (pH 8.0),
8 M urea) and centrifuged again at 12,000 × g
for 15 min at 4 °C. Thereafter, 300 µl of a 50% slurry of
Ni2+-NTA agarose (Qiagen) equilibrated with buffer A was
added to the supernatant and gently mixed for 1 h. The resin was washed
three times with 10 ml of buffer B (same composition as buffer A but
the pH was adjusted with 6.3), and the protein bound to
Ni2+-NTA agarose was finally eluted with 500 µl of buffer
B containing 0.2 M imidazole. The eluted protein was
sequentially dialyzed against buffer C (20 mM Tris-HCl (pH
7.5), 0.5 M NaCl, 50% glycerol, 0.1 mM
phenylmethylsulfonyl fluoride) containing 6, 4, 2, and 0 M
urea. The purity of each protein obtained was estimated to be between
67% and 93%, based on laser densitometry of the Coomassie Brilliant
Blue-stained gel using a BioImage Analyzer (Millipore/MilliGen).
Gel Retardation Assay
To prepare radiolabeled scRNA
in vitro, a 120-bp EcoRI-BamHI
fragment of pTUBE823 (39) was inserted into the
EcoRI-BamHI sites of plasmid pSP64 (Pharmacia
Biotech Inc.). The resulting plasmid, in which the gene encoding sc104
RNA (nucleotide positions 116 to 219 in the mature form of scRNA) was
positioned downstream of SP6 promoter in the correct direction, was
designated pTUE953. To transcribe sc104 RNA in vitro, the
plasmid pTUE953 linearized by BamHI digestion was incubated
with 35 units of SP6 RNA polymerase in the transcription buffer (40
mM Tris-HCl (pH 7.5), 6 mM MgCl2,
10 mM NaCl, 10 mM dithiothreitol, 2
mM spermidine) containing 0.5 mM each of GTP,
ATP, UTP, 100 µM CTP, and 50 µCi of
[ -32P]CTP at 37 °C for 1 h.
To evaluate the binding activity, the proteins (5 pmol each) were
incubated with labeled sc104 RNA (2 × 103 cpm) in a buffer
(15 mM HEPES (pH 7.9), 50 mM KCl, 6
mM MgCl2, 50 mM NaCl, 20%
glycerol, 0.3% VRC, 1 unit of poly(dI-dC), 0.01% bovine serum
albumin) at 30 °C for 30 min. Thereafter, the samples were resolved
by electrophoresis on 4% native polyacrylamide gels containing 0.5 ×
TBE and 2.5% glycerol. The gels were dried and exposed to a x-ray film
(Fuji Photo Film Co., Ltd., Tokyo) and autoradiographed. The density of
the shifted bands was quantified using a Bio Image Analyzer
(Millipore/MilliGen).
Nitrocellulose Filter Assay
The 32P-labeled
sc104 RNA (0.15 nM, 1.3 × 1018 cpm/mol) was
incubated with various concentrations of Ffh and its derivatives (1
nM to 10 µM) in 10 µl of a buffer (10
mM Tris-HCl (pH 7.4), 10 mM MgCl2,
50 mM NaCl, 0.3% VRC, 1 unit of poly(dI-dC)) for 1 min at
room temperature. The mixtures were then diluted with 0.5 ml of wash
buffer (20 mM Tris-HCl (pH 7.4), 10 mM
MgCl2, 100 mM NaCl, 10% glycerol). The
resulting solutions were immediately passed through nitrocellulose
filters (ADVANTEC, 0.45 µm or 0.20 µm pore size; TOYO ROSHI KAISHA
Ltd., Tokyo), which were washed with 1.5 ml of wash buffer. The levels
of radioactivity remaining on the nitrocellulose filters were
determined by a liquid scintillation counter (Beckman, LS5000TA).
RESULTS
Binding of Wild-type Ffh with sc104 RNA in Vitro
To prepare
the purified Ffh protein, we constructed the E. coli plasmid
pTUE920 that encoded Ffh with a hexahistidine tag at its C terminus. We
then examined the effect of adding the hexahistidine tag to Ffh
in vivo. The ffh conditional mutant, B.
subtilis NA20BF in which the expression of ffh is
controlled by the Pspac-1 promoter (23), cannot grow in the
absence of 1 mM IPTG. However, the growth in the absence of
IPTG was complemented by the introduction of pTUBE911, in which the
B. subtilis ffh gene was placed under the control of the
protein A promoter, into the cells as well as by that of pTUBE917, in
which a gene for ffh with a hexahistidine tag at its C
terminus was placed under the control of the protein A promoter.
Therefore, we constructed pTUE920 and prepared B. subtilis
Ffh with a hexahistidine tag from an E. coli transformant as
the wild-type Ffh of B. subtilis. The preparation was
designated as Ffh-WT. The purity of the sample was over 85% according
to laser densitometry of the Coomassie Brilliant Blue stained gel after
SDS-polyacrylamide gel electrophoresis.
As shown in Fig. 1A, a distinct band migrated
much more slowly than the free sc104 RNA in a nondenaturing gel when
32P-labeled sc104 RNA, a derivative of scRNA, was incubated
with Ffh-WT (lane 2). This band disappeared upon adding a
250-fold excess of non-radiolabeled scRNA (sc271) or sc104 RNA, but not
250-fold excess of tRNA as a competitor (lanes 3-5).
Although a slowly migrating band was also detected using scRNA (sc271)
as a probe in the presence of Ffh, it was closer to the band of the
free probe than those of sc104 RNA (data not shown). Wild-type scRNA
consisting of 271 nucleotides (sc271) was too large to be used as a
probe in the gel retardation and filter binding assays. The Zuker
minimal energy program (38) predicted that sc104 RNA could almost form
a hairpin structure similar to that of wild-type of scRNA. Therefore,
to monitor the formation of the complex between B. subtilis
Ffh and scRNA in vitro, we used sc104 RNA corresponding to
positions 116 to 219 of scRNA, which lacked helix 1~4, and most of
helix 5, but remained helix 8. The size of sc104 RNA is similar to that
of E. coli 4.5 S RNA, which is a counterpart of scRNA.
Furthermore, a scRNA of smaller size is functional in vivo,
since the sc104 RNA complements the growth defect caused by depleting
scRNA form B. subtilis (39). In this study, sc104 RNA was
used for the gel retardation and filter assays instead of wild-type
scRNA (sc271). The dose dependence of the binding of wild-type Ffh and
sc104 RNA was also examined by a filter binding assay. Up to 10
µM Ffh, the amount of sc104 RNA bound to Ffh increased as
Ffh added (Fig. 1B). The binding curve of M.
mycoides Ffh protein is also sigmoidal (34). The half-maximal
binding (M1/2) was approximately 0.15
µM.
Fig. 1.
The binding of wild-type Ffh with
scRNA. A, gel retardation assay. 32P-Labeled
sc104 RNA was incubated with (lane 2) or without (lane
1) 0.5 pmol of Ffh for 30 min at 30 °C. The specificity of the
interaction between Ffh and scRNA was estimated in the presence of a
250-fold excess of unlabeled wild-type scRNA (sc271, lane
3), sc104 RNA (lane 4), and tRNAPhe
(lane 5), as competitors in the presence of Ffh. Slowly
migrating bands are indicated by an arrowhead. B,
assay of the complex between wild-type Ffh and sc104 RNA on
nitrocellulose filters. Various concentrations of wild-type Ffh were
incubated with 0.15 nM labeled sc104 RNA, and the retention
of the Ffh-sc104 RNA complex on nitrocellulose filters was monitored.
RNA bound was defined as follows: percent RNA retained = retained
labeled RNA on filter (cpm) × 100/added labeled RNA (cpm)
scRNA Binding by the Large Deletion Mutants of Ffh
To search
the RNA-binding region of Ffh protein, purified mutant proteins were
used in the RNA-binding assay. Ffh- G lacks most of the G-domain
(Fig. 2A), and it bound to sc104 RNA in the
gel retardation (Fig. 2B) and filter assays (Fig.
2C). In contrast, Ffh- M lacking the M-domain had no
affinity for sc104 RNA in either assay (Fig. 2, B and
C). Therefore, like mammalian SRP54, the RNA-binding domain
of B. subtilis Ffh is also located in the M-domain. Since
the binding activity data determined by the gel retardation and filter
assays were consistent, we employed the filter assay to further studies
as the quantitative analysis of the interaction between derivatives of
Ffh and scRNA.
Fig. 2.
RNA-binding activities of Ffh- G and
Ffh- M. A, schematic structures of Ffh-WT, Ffh- G, and
Ffh- M. The positions of three GTP-binding motifs (I to
III) in G-domain and three hydrophobic regions (h1, 307 to
331; h2, 364 to 391; and h3, 416 to 435 amino acid positions) in
M-domain are indicated. The ruler at the top of
the figure indicates the approximate amino acid position of Ffh. The
numbers on each diagram indicate the amino acid positions of the
termini of deletion. The numbers below the name of each mutant protein
indicate the amino acid length for Ffh-WT and the deleted amino acid
positions for Ffh- G and Ffh- M. B, gel retardation
assay of Ffh- G and - M. Gel retardation assays were performed by
incubating 32P-labeled sc104 RNA with each Ffh protein (0.5
pmol) for 30 min at 30 °C. The Ffh proteins added to the reaction
mixture were: lane 1, no Ffh proteins; lane 2,
wild-type Ffh; lane 3, Ffh- M; lane 4,
Ffh- G; arrowheads indicate the slowly migrating bands.
C, filter assay of Ffh- G and- M. Ffh-WT ( ), Ffh- G
( ), and Ffh- M ( ) were monitored by means of the filter assay
as described under ``Experimental Procedures.''
Using a series of large deletion mutant proteins of Ffh (Fig.
3A), we searched the region that binds to
scRNA in Ffh (Fig. 3B). Neither Ffh- h3, Ffh- h3
(deleted amino acid positions 392 to 446 and 413 to 446, respectively),
nor Ffh- h2 (deleted amino acid positions from 338 to 397) bound to
sc104 RNA. In contrast, Ffh- h1 (deleted amino acid positions from
311 to 362) and Ffh- C (deleted 14 amino acids at the C-terminal
region) bound to sc104 RNA with the same affinity as that of wild-type
Ffh. These results show that the region of Ffh spanning positions 364
to 432 and corresponding to the region from h2 to h3, is necessary for
scRNA binding. Furthermore, the results using the other Ffh
derivatives, Ffh- h23 (deleted amino acids from position 364 to 446
including the h2 and h3 regions) and Ffh- h12 (deleted amino acids
from position 311 to 415 including the h1 and h2 regions), were
consistent with this conclusion, because these two Ffh derivatives
could not bind sc104 RNA (Fig. 3B). When these mutant Ffh
proteins were introduced into B. subtilis NA20BF, only
Ffh- C completely restored the growth defect of NA20BF in the absence
of IPTG, whereas the others only partially did so (data not shown). All
mutant Ffh protein except for Ffh- G mutant was shown to hydrolyze
GTP the same as Ffh-WT (data not shown).
Fig. 3.
RNA-binding activities of large deletion
derivatives of Ffh. A, schematic structures of deletion
derivatives of Ffh. The numbers below the name of each mutant protein
indicate the deleted amino acid positions. B, filter assay
of deletion derivatives of Ffh. Ffh-WT ( ), - C ( ), - h3
( ), - h3 ( ), - h23 ( ), - h2 ( ), - h12 ( ), and
- h1 ( ) were monitored by filter assays as described in the legend
to Fig. 2.
scRNA Binding of Amino Acids Replaced and Short Deletion Mutant
Proteins of Ffh
The results shown above indicate that the peptide
region from position 364 to 432 of B. subtilis Ffh is
necessary for its binding with sc104 RNA. The hydrophobic regions, h2
and h3, were highly conserved among identified SRP54 homologues.
Furthermore, B. subtilis Ffh bound 4.5 S RNA and SRP RNA
because several characteristic features caused by the depletion of
scRNA in B. subtilis were functionally compensated by the
expression of human SRP RNA or E. coli 4.5 S RNA (40). These
facts suggested that the conserved amino acid residues in the region of
amino acid positions 364 to 432 contributed to the RNA binding.
Furthermore, there are positively charged and aromatic residues located
on several RNA-binding motifs (41). Based upon a comparison of the
amino acid sequences of B. subtilis Ffh, E. coli
Ffh, and mammalian SRP54, conserved positively charged and aromatic
amino acids in the hydrophobic h2 and h3 regions and the region between
them were replaced by site-directed mutagenesis using the
oligonucleotides described under ``Experimental Procedures'' (Fig.
4). The mutants proteins were designated as K364M
(Lys-364 was replaced with Met), K371M (Lys-371 was replaced with Met),
H375Q (His-375 was replaced with Gln), F428Q (Phe-428 was replaced with
Gln), K428M (Lys-428 was replaced with Met), and K435M (Lys-435 was
replaced with Met). The sequence RRKR (positions 398 to 401 in B.
subtilis), a remarkable basic amino acid cluster located between
the h2 and h3 regions was replaced with four glutamine residues, the
mutant Ffh contained QQQQ. The sequence GSG (position at 405 to 407 in
B. subtilis) was deleted and designed as GSG. The
sequence GXG was highly conserved in the amino acid
sequences among SRP54 and its homologues.
Fig. 4.
Comparisons of amino acid sequences at the
region of h2 and h3 in M-domain of SRP54 homologues. Bs,
B. subtilis (23); Ec, E. coli (24);
AtCP, A. thaliana chloroplast (22);
Mm, M. mycoides (17); Cf, C.
familiaris (10); At, A. thaliana (21);
Sc, S. cerevisiae (19, 20); and Sp,
S. pombe (19) were aligned. Highly conserved residues with
all SRP54 homologues are shown in the on the black boxes in
reverse type. Only conserved residues with each group of
Eubacteria or Eukaryotes are shown in the gray shaded boxes.
On the top is a diagram of the residues replaced in this study.
The RNA-binding activity of wild-type and mutant Ffh proteins with
sc104 RNA was assayed using nitrocellulose filters (Fig.
5A), and the activity of each mutant protein
is shown as a percentage of that of wild-type Ffh at a concentration of
1 µM protein added to the reaction mixture (Fig.
5B). K364M, K371M, H375Q, and F420Q had activity similar to
that of Ffh-WT, and the binding activities of K428M and K435M were
reduced to 78 and 59% of that of Ffh-WT. In contrast, the QQQQ and
GSG mutant proteins had no binding activity.
Fig. 5.
RNA-binding activities of Ffh
derivatives. A, filter assay of amino acid replaced and
short deleted derivatives of Ffh. Ffh-WT ( ), K364M ( ), K371M
( ), H375Q ( ), QQQQ ( ), F420Q ( ), K428M ( ), K435M ( ),
and GSG ( ) were monitored by filter assays described in the
legend to Fig. 2. B, relative RNA-binding activities of Ffh
derivatives. RNA-binding activities were shown as a percentage of that
of Ffh-WT at the concentration of 1 µM protein added to
the reaction mixture.
These results indicated that the shorter region between h2 and h3 of
the Ffh M-domain is very important for the binding to sc104 RNA, and
that the positively charged amino acids in h2 (amino acids position 346
to 391) and h3 (amino acids position 416 to 435) are less important
than the shorter region. The short peptide sequence between h2 and h3
constitutes one of the most highly conserved regions in the M-domains
of SRP54 proteins. Furthermore, the two arginine residues among
sequences RRKR (italic), and GSG were especially
highly conserved in the short region between the h2 and h3 regions
among SRP54 homologues (Fig. 4).
RNA-binding Activity in Mutant Ffh Proteins at the RRKR
Sequence
The cluster of four positively charged amino acids
located between the hydrophobic region h2 and h3 has also been found in
the SRP54 homologues of M. mycoides (17) and in chloroplasts
of Arabidopsis thaliana (22) (Fig. 4). Furthermore, a
similar structure, RXXR, has been identified in the h2 and
h3 regions of Eukarya, Canis familiaris (10), Mus
musculus (9), Lycopersicon esculentum (18), A.
thaliana (21), Schizosaccharomyces pombe (19), and
Saccharomyces cerevisiae (19, 20), as shown in Fig. 4. Since
the QQQQ derivative of B. subtilis Ffh completely lacked
RNA-binding activity, we prepared three novel derivatives (RQQR, RQQQ,
and QQQR). As shown in Fig. 6, the RQQR and QQQR
derivatives had similar RNA-binding activities, whereas that of RQQQ
was dramatically reduced. Therefore, the arginine residue at position
401 (R401) of 398RRKR401 in B.
subtilis Ffh was essential for the RNA-binding activity.
Fig. 6.
RNA-binding activities of Ffh mutant at the
RRKR sequence. Ffh-WT ( ), RQQR ( ), QQQR ( ), RQQQ ( ),
and QQQQ ( ) were monitored by filter assays described in the legend
to Fig. 2.
RNA-binding Activity of Mutant Ffh Proteins at the GSG
Sequence
The GSG sequence is highly conserved among SRP54 and its
homologues. To determine whether or not the secondary structure of this
region is closely involved in RNA-binding activity, ASA (two glycines
were replaced with alanine) and PSP (two glycines were replaced with
proline) derivatives were prepared. The RNA-binding activity of both
ASA and PSP derivatives was reduced dramatically (Fig.
7). We then prepared the GSP and PSG derivatives to
determine which glycine residue of the GSG sequence is more important
for RNA binding. Neither PSG nor GSP derivatives bound to sc104 RNA
(Fig. 7). These results indicated that the GSG sequence is crucial for
the RNA-binding activity of Ffh.
Fig. 7.
RNA-binding activities of Ffh mutant at the
GSG sequence. Ffh-WT ( ), ASA ( ), PSP ( ), PSG ( ), and
GSP ( ) were monitored by filter assays described in the legend to
Fig. 2.
Lys-404 Replacements of Ffh Protein Affected the RNA-binding
Activity
A positively charged amino acid between RRKR and GSG
sequences, such as Lys-404 of B. subtilis Ffh protein, was
conserved among most SRP54 and its homologues, except for E.
coli Ffh. To confirm that Lys-404 of B. subtilis Ffh is
necessary for RNA binding, we constructed three novel replacement
mutants in which Lys-404 was replaced with Gln (K404Q), RRKR-K404Q,
RQQR-K404Q, and QQQR-K404Q and monitored the RNA-binding activity. All
of the K404Q replacements significantly reduced the RNA-binding
activity. The half-maximal bindings for Ffh-WT, RRKR-K404Q, RQQR-K404Q,
and QQQR-K404Q were 0.15, 0.5, 0.7, and 2.0 µM,
respectively (Fig. 8). Since replacing Arg-398 with Gln
with K404Q replacement reduced the binding activity even more
(comparing that of RQQR-K404Q and QQQR-K404Q), both Arg-398 and Lys-404
are necessary for binding to scRNA.
Fig. 8.
RNA-binding activities of K404Q
derivatives. Ffh-WT ( ), RRKR-K404Q ( ), RQQR-K404Q ( ), and
QQQR-K404Q ( ) were monitored by filter assays as described in the
legend to Fig. 2.
RNA-binding Activity of MH23 Peptide and a Synthetic Peptide (a
24-Amino Acid Peptide)
Based upon the findings that the region
from position 364 to 432 of Ffh is necessary for its binding with scRNA
as shown in Fig. 3, we determined whether the peptide of this region
was sufficient for the binding to scRNA. We constructed the MH23
peptide corresponding to amino acid positions 356 to 446, which
included the peptide region from h2 to h3 (Fig.
9A) and assayed the RNA-binding activity
using nitrocellulose filters. The MH23 peptide bound to sc104 RNA with
the same affinity as Ffh-WT (Fig. 9B).
Fig. 9.
RNA-binding activities of MH23 and a
synthetic peptide. A, schematic structures of MH23 and
synthetic peptide. The numbers below the name of each peptide indicate
the amino acid length. The amino acid sequence of the synthetic peptide
is showed below the diagram. B, filter assay of MH23 and the
synthetic peptide. Ffh-WT ( ), MH23 ( ), and the synthetic peptide
( ) were monitored by filter assays using 0.45- and 0.20-µm pore
size nitrocellulose filters as described in the legend to Fig. 2.
Furthermore, to determine whether or not the region between h2 and h3
regions is sufficient for the binding to scRNA, we synthesized a
peptide consisting of 24 amino acid residues (amino acid positions 392
to 415) corresponding to the stretch between these regions (Fig.
9A). This synthetic peptide did not bind sc104 RNA according
to the nitrocellulose filter assay (Fig. 9B). Additionally,
under the conditions shown in Fig. 9B, a 1000-fold excess of
the synthetic peptide did not compete with the RNA-binding activities
of either Ffh-WT or MH23 in the nitrocellulose filter assay (data not
shown).
In total, these results showed that the 24 amino acids contained a
region that was essential, but not sufficient, for binding to scRNA. In
contrast, the amino acids positions spanning 354 to 446 were sufficient
for the binding to scRNA. The data indicated that not only 24 amino
acids but also the adjacent regions, h2 and h3, were necessary for the
binding to scRNA.
DISCUSSION
The results of this study indicated that in B. subtilis
Ffh-scRNA complex the peptide from amino acid position 364 to 432 of
B. subtilis Ffh, including two conserved hydrophobic regions
(h2 and h3), is necessary and sufficient for scRNA binding. Point
mutations within the region between h2 and h3 dramatically affected the
RNA-binding activity. Substitutions of Arg-401 and substitution of two
glycine residues in the GSG sequence abolished the binding, suggesting
that these amino acid residues bind directly to RNA. The RQQR
derivative of B. subtilis Ffh showed the same binding
activity as Ffh-WT (Fig. 5). The RXXR sequence in this
region is found in SRP54 of C. familiaris in which the amino
acid sequence of the corresponding region is
IQ VA (the conserved amino
acids are underlined). Moreover, mammalian SRP54 can bind bacterial SRP
RNA (33). These data indicated that two conserved positively charged
residues in this sequence are necessary for RNA binding. On the other
hand, effect of the introduction of amino acid substitutions into the
h2 and h3 regions is less than that positively charged residues.
Computer-assisted secondary structure analysis of this region suggested
that both hydrophobic regions (h2 and h3) fold into an amphipathic
-helix, with methionine and other hydrophobic residues clustered on
one face (9). The positively charged amino acid residues clustered in
the predicted boundaries between two helices. Therefore, it is more
plausible that h2 and h3 cannot bind directly to RNA, but that a
secondary or tertiary structure formed by h2 and h3 plays a pivotal
role in RNA binding. This model is supported by our data showing that a
chemically synthesized oligopeptide (corresponding to amino acid
positions 392 to 415) could not bind to RNA by itself (Fig. 9) and did
not interfere with RNA binding of Ffh-WT (data not shown). Furthermore,
Ffh- h3, which contains the RRKRIAKGSG sequence but not the h3
region, had no binding ability.
The nucleotide sequence and secondary structure of helix 8 of SRP RNAs
are highly conserved. This domain consists of an extended stem-loop
structure. Moreover, highly conserved and invariant residues lie within
the tetranucleotide loop (30). Mammalian SRP54 protein is homologous to
bacterial Ffh protein, and it can bind 4.5 S RNA (33), suggesting that
these conserved nucleotides within the stem-loop structure region are
important for binding. Using an in vitro binding assay, Wood
et al. (32) have shown that the evolutionarily conserved
residues within the stem structure of 4.5 S RNA including the bulged
region, are required for Ffh binding rather than conserved residues
within the tetranucleotide loop. This suggests that the SRP54 family
consists of double-stranded RNA (dsRNA)-binding proteins. Computer
searches revealed a nonsignificant relatedness between Ffh and other
cellular (RNA-binding) proteins. However, a reduced set of amino acids
in the RRKRIAKGSG sequence of Ffh was similar to a consensus sequence
(GXGXSKKXAK) found in dsRNA-binding
proteins, such as E. coli RNaseIII, human immunodeficiency
virus type I (HIV I) TRBP (TAR RNA-binding protein),
Drosophila mRNA localization protein staufen, and human
P1/dsI kinase (42). The tertiary structure of RNaseIII has been
elucidated by NMR (43). In the RNA-binding domain of RNaseIII
containing the consensus sequence, three-stranded antiparallel
-sheets are packed on one side against the two helices, and this
structure exposes positively charged amino acids to facilitate RNA
binding. On the other hand, a similar sequence has also been found in
E. coli protein synthesis elongation factor G
(EF-G).2 This structural feature has been
discovered in the C-terminal region of Thermus thermophilus
EF-G by determination of the crystal structure (44). A deletion of the
corresponding region of E. coli EF-G abolished the activity
of ribosome binding (45). This suggests that this structure is
essential for binding to 23 S rRNA (46, 47), since EF-G interacts with
the ribosome through the 23 S rRNA. These data indicate that not only
the amino acid sequence, but also positively charged residues exposed
by encompassing higher structures, are conserved among dsRNA-binding
domains.
In this study, we concluded that amino acids 364 to 432, which include
the hydrophobic h2 and h3 that will form an -helix structure and the
positively charged conserved region between these helices, are critical
for RNA binding. Therefore, it would be useful to determine the crystal
structure of the RNA-binding region of Ffh for further understanding
the structure-function relationship of double-stranded RNA motifs.
FOOTNOTES
*
This work was supported in part by grants-in-aid for
scientific research from the Ministry of Education, Science and Culture
of Japan. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Institute of
Biological Sciences, University of Tsukuba, Tsukuba-shi, Ibaraki 305,
Japan. Tel./Fax: 81-298-53-6680; E-mail:
kyamane{at}sakura.cc.tsukuba.ac.jp.
1
The abbreviations used are: SRP, signal
recognition particle; scRNA, small cytoplasmic RNA; kb, kilobase(s);
bp, base pair(s); PCR, polymerase chain reaction; IPTG,
isopropyl-1-thio- -D-galactopyranoside; ds,
double-stranded.
2
Shibata, T., Fujii, Y., Nakamura, Y., Nakamura,
K., and Yamane, K. (1996) J. Biol. Chem. 271,
13162-13168.
Acknowledgment
We thank N. Foster for critical reading of the
manuscript.
REFERENCES
-
Siegel, V.,
Walter, P.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
1801-1805
[Abstract/Free Full Text]
-
Walter, P.,
Blobel, G.
(1982)
Nature
299,
691-698
[CrossRef][Medline]
[Order article via Infotrieve]
-
Walter, P.,
Blobel, G.
(1981)
J. Cell Biol.
91,
557-561
[Abstract/Free Full Text]
-
Walter, P.,
Ibrahimi, I.,
Blobel, G.
(1981)
J. Cell Biol.
91,
545-550
[Abstract/Free Full Text]
-
Meyer, D. I.,
Krause, E.,
Dobberstein, B.
(1982)
Nature
297,
647-650
[CrossRef][Medline]
[Order article via Infotrieve]
-
Krieg, U. C.,
Walter, P.,
Johnson, A. E.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8604-8608
[Abstract/Free Full Text]
-
Kurzchalia, T. V.,
Wiedmann, M.,
Girshovich, A. S.,
Bochkareva, E. S.,
Bielka, H.,
Rapoport, T. A.
(1986)
Nature
320,
634-636
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wiedmann, M.,
Kurzchalia, T. V.,
Bielka, H.,
Rapoport, T. A.
(1987)
J. Cell Biol.
104,
201-208
[Abstract/Free Full Text]
-
Bernstein, H. D.,
Poritz, M. A.,
Strub, K.,
Hoben, P. J.,
Brenner, S.,
Walter, P.
(1989)
Nature
340,
482-486
[CrossRef][Medline]
[Order article via Infotrieve]
-
Römisch, K.,
Webb, J.,
Herz, J.,
Prehn, S.,
Frank, R.,
Vingron, M.,
Dobberstein, B.
(1989)
Nature
340,
478-482
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zopf, D.,
Bernstein, H. D.,
Walter, P.
(1993)
J. Cell Biol.
120,
1113-1121
[Abstract/Free Full Text]
-
High, S.,
Dobberstein, B.
(1991)
J. Cell Biol.
113,
229-233
[Abstract/Free Full Text]
-
Lütcke, H.,
High, S.,
Römisch, K.,
Ashfold, A. J.,
Dobberstein, B.
(1992)
EMBO J.
11,
1543-1551
[Medline]
[Order article via Infotrieve]
-
Römisch, K.,
Webb, J.,
Lingerbach, K.,
Gausepohl, H.,
Dobberstein, B.
(1990)
J. Cell Biol.
111,
1793-1802
[Abstract/Free Full Text]
-
Zopf, D.,
Bernstein, H. D.,
Johnson, A. E.,
Walter, P.
(1990)
EMBO J.
9,
4511-4571
[Medline]
[Order article via Infotrieve]
-
Czarnota, G. J.,
Andrews, D. W.,
Farrow, N. A.,
Ottensmeyer, F. P.
(1994)
J. Struct. Biol.
113,
35-46
[CrossRef][Medline]
[Order article via Infotrieve]
-
Samuelsson, T.
(1992)
Nucleic Acids Res.
20,
5763-5770
[Abstract/Free Full Text]
-
Krolkiewicz, S.,
Sänger, H. L.,
Niesbach-Klösgen, U.
(1994)
Mol. & Gen. Genet.
245,
565-576
-
Hann, B. C.,
Poritz, M. A.,
Walter, P.
(1989)
J. Cell Biol.
109,
3223-3230
[Abstract/Free Full Text]
-
Amaya, Y.,
Nakano, A.,
Ito, K.,
Mori, M.
(1990)
J. Biochem.
Tokyo
107,
457-463
[Abstract/Free Full Text]
-
Lindstorm, J. T.,
Chu, B.,
Belanger, F. C.
(1993)
Plant Mol. Biol.
23,
1265-1272
[CrossRef][Medline]
[Order article via Infotrieve]
-
Franklin, A. E.,
Hoffmann, N. E.
(1993)
J. Biol. Chem.
268,
22175-22180
[Abstract/Free Full Text]
-
Honda, K.,
Nakamura, K.,
Nishiguchi, M.,
Yamane, K.
(1993)
J. Bacteriol.
175,
4885-4894
[Abstract/Free Full Text]
-
Byström, A. S.,
Hjalmarsson, K. J.,
Wikström, P. M.,
Björk, G. R.
(1983)
EMBO J.
2,
899-905
[Medline]
[Order article via Infotrieve]
-
Poritz, M. A.,
Bernstein, H. D.,
Strub, K.,
Zopf, D.,
Wilhelm, H.,
Walter, P.
(1990)
Science
250,
1111-1117
[Abstract/Free Full Text]
-
Nakamura, K.,
Nishiguchi, M.,
Honda, K.,
Yamane, K.
(1994)
Biochem. Biophys. Res. Commun.
199,
1394-1399
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hann, B. C.,
Walter, P.
(1991)
Cell
67,
131-144
[CrossRef][Medline]
[Order article via Infotrieve]
-
Selinger, D.,
Brennwald, P.,
Althoff, S.,
Reich, C.,
Hann, B.,
Walter, P.,
Wise, J. A.
(1994)
Nucleic Acids Res.
22,
2557-2567
[Abstract/Free Full Text]
-
Luirink, J.,
High, S.,
Wood, H.,
Giner, A.,
Tollervey, D.,
Dobberstein, B.
(1992)
Nature
359,
741-743
[CrossRef][Medline]
[Order article via Infotrieve]
-
Larsen, N.,
Zweib, C.
(1991)
Nucleic Acids Res.
19,
209-215
[Abstract/Free Full Text]
-
Selinger, D.,
Brennwald, P.,
Liao, X.,
Wise, J. A.
(1993)
Mol. Cell. Biol.
13,
1353-1362
[Abstract/Free Full Text]
-
Wood, H.,
Luirink, J.,
Tollervey, D.
(1992)
Nucleic Acids Res.
20,
5919-5925
[Abstract/Free Full Text]
-
Ribes, V.,
Römisch, K.,
Giner, A.,
Dobberstein, B.,
Tollervey, D.
(1990)
Cell
63,
591-600
[CrossRef][Medline]
[Order article via Infotrieve]
-
Samuelsson, T.,
Olsson, M.
(1993)
Nucleic Acids Res.
21,
847-853
[Abstract/Free Full Text]
-
Kunkel, T. A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492
[Abstract/Free Full Text]
-
Kunkel, T. A.,
Roberts, J. D.,
Zakour, R. A.
(1987)
Methods Enzymol.
154,
367-382
[Medline]
[Order article via Infotrieve]
-
Lifson, J. D.,
Hwang, K. M.,
Nara, P. L.,
Fraser, B.,
Padgett, M.,
Dunlop, N. M.,
Eiden, L. E.
(1988)
Science
241,
712-716
[Abstract/Free Full Text]
-
Jaeger, J. A.,
Turner, D. H.,
Zuker, M.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7706-7710
[Abstract/Free Full Text]
-
Nishiguchi, M.,
Honda, K.,
Amikura, R.,
Nakamura, K.,
Yamane, K.
(1994)
J. Bacteriol.
176,
157-165
[Abstract/Free Full Text]
-
Nakamura, K.,
Imai, Y.,
Nakamura, A.,
Yamane, K.
(1992)
J. Bacteriol.
174,
2185-2192
[Abstract/Free Full Text]
-
Burd, C. G.,
Dreyfuss, G.
(1994)
Science
265,
615-621
[Abstract/Free Full Text]
-
Johnston, D. S.,
Brown, N. H.,
Gall, J. G.,
Jantsch, M.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10979-10983
[Abstract/Free Full Text]
-
Kharrat, A.,
Macias, M. J.,
Gibson, T. J.,
Nilges, M.,
Pastore, A.
(1995)
EMBO J.
14,
3572-3584
[Medline]
[Order article via Infotrieve]
-
Jvarsson, A.,
Brazhnikov, E.,
Garber, M.,
Zherltonosova, J.,
Chirgadze,
Yu,
Al-Karadaghi, S.,
Suensson, L. A.,
Liljas, A.
(1994)
EMBO J.
13,
3669-3677
[Medline]
[Order article via Infotrieve]
-
Hou, Y.,
Yaskowiak, E. S.,
March, P.
(1994)
J. Bacteriol.
176,
7038-7044
[Abstract/Free Full Text]
-
Sköld, S.-E.
(1983)
Nucleic Acids Res.
11,
4923-4932
[Abstract/Free Full Text]
-
Moazed, D.,
Robertson, J. M.,
Noller, H. F.
(1988)
Nature
334,
362-364
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. H. A. Kremer, M. van der Kraan, P. J. Crowley, I. R. Hamilton, L. J. Brady, and A. S. Bleiweis
Characterization of the sat Operon in Streptococcus mutans: Evidence for a Role of Ffh in Acid Tolerance
J. Bacteriol.,
April 15, 2001;
183(8):
2543 - 2552.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Yamanaka, J. Hwang, and M. Inouye
Characterization of GTPase Activity of TrmE, a Member of a Novel GTPase Superfamily, from Thermotoga maritima
J. Bacteriol.,
December 15, 2000;
182(24):
7078 - 7082.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. T. Batey, R. P. Rambo, L. Lucast, B. Rha, and J. A. Doudna
Crystal Structure of the Ribonucleoprotein Core of the Signal Recognition Particle
Science,
February 18, 2000;
287(5456):
1232 - 1239.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. I. Meier, R. B. Peery, S. R. Jaskunas, and G. Zhao
16S rRNA Is Bound to Era of Streptococcus pneumoniae
J. Bacteriol.,
September 1, 1999;
181(17):
5242 - 5249.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. W. Navarre and O. Schneewind
Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope
Microbiol. Mol. Biol. Rev.,
March 1, 1999;
63(1):
174 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|